Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,472
Recruiting: 1,283
Ph III recruiting: 130
Growth YoY: +4.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,642)

clinicaltrialsPublishedShowing 4,401–4,450 of 4,946 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00104819	Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma	terminated	Phase 2	238	FavrilleINDUSTRY	1	Aug 2, 2013	clinicaltrials
NCT00499343	G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients	completed	Phase 2	84	M.D. Anderson Cancer CenterOTHER	1	Aug 2, 2013	clinicaltrials
NCT00720447